UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000035941
Receipt No. R000040929
Scientific Title FFR guided DecISion making in COronary reVascularization: Japanese multi-cEnteR retrospective RegistrY
Date of disclosure of the study information 2019/02/20
Last modified on 2022/08/04 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title FFR guided DecISion making in COronary reVascularization: Japanese multi-cEnteR retrospective RegistrY
Acronym FFR DISCOVERY Japan
Scientific Title FFR guided DecISion making in COronary reVascularization: Japanese multi-cEnteR retrospective RegistrY
Scientific Title:Acronym FFR DISCOVERY Japan
Region
Japan

Condition
Condition Coronary artery disease
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 1) To elucidate the prognosis of patients after fractional flow reserve assessments
2) To clarify the optimal cut-off value of FFR for coronary revascularization on the basis of clinical outcomes
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes time to event for cardiac death, myocardial infarction, and target lesion revascularization
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who underwent fractional flow reserve assessment in one or more coronary arteries
Key exclusion criteria 1) Infarct related artery
2) Bypass graft
3) Thrombolysis in myocardial infarction flow (TIMI) <3
4) Overt heart failure
5) Severe valvular disease or cardiomyopathy (Hypertrophic, dilated, or restrictive cardiomyopathy)
6) Limited life expectancy (less than 12 months)
7) If patients or their family elect to opt out of study participation
Target sample size 5000

Research contact person
Name of lead principal investigator
1st name Takashi
Middle name
Last name Akasaka
Organization Wakayama Medical University
Division name Department of cardiovascular medicine
Zip code 641-8510
Address 811-1 Kimiidera Wakayama Japan
TEL 073-447-2300
Email akasat@wakayama-med.acj.jp

Public contact
Name of contact person
1st name Yasutsugu
Middle name
Last name Shiono
Organization Wakayama Medical University
Division name Department of cardiovascular medicine
Zip code 641-8510
Address 811-1 Kimiidera Wakayama Japan
TEL 073-447-2300
Homepage URL
Email yshiono@wakayama-med.ac.jp

Sponsor
Institute Wakayama Medical University
Institute
Department

Funding Source
Organization Japan Heart Foundation
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Wakayama Medical University
Address 811-1 Kimiidera Wakayama Japan
Tel 073-447-2300
Email wa-rinri@wakayama-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 和歌山県立医科大学 (和歌山県)
東京医科大学 (東京都)
東京医科大学八王子医療センター (東京都)
岐阜ハートセンター (岐阜県)
京都第二赤十字病院 (京都府)
愛知医科大学 (愛知県)
江戸川病院 (東京都)

Other administrative information
Date of disclosure of the study information
2019 Year 02 Month 20 Day

Related information
URL releasing protocol NA
Publication of results Unpublished

Result
URL related to results and publications NA
Number of participants that the trial has enrolled 5007
Results A total of 5004 patients who underwent FFR measurement between 2010 and 2016 were enrolled and were followed until March 2020.
Of those, 2886 patients underwent revascularization after FFR measurements. During the follow up, 87 patients suffered from cardiac death and 59 patients suffered non-fatal myocardial infarction.
Results date posted
2022 Year 08 Month 04 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics Among the patients enrolled in this study, 3728 (74.5%) were men, the average age was 69.7, 3783(75.6%) had chronic coronary syndrome, 659 (13.2%) had prior myocardial infarction, 421 (8.4%) had unstable angina, 118 (2.4%) had ST-segment elevated myocardial infarction, and 23 (0.5%) had non-ST-segment elevated myocardial infarction. 4026 (80.5) patients had hypertension, 3354 (67%) had dyslipidemia, 2098 (41.9%) had diabetes mellitus, 1268 (25.3%) had prior myocardial infarction, 462 (9.2%) had chronic kidney disease, 340 were on hemodyalysis, 541 (10.8%) had peripheral artery disease, 499 (10.0%) had prior stroke, and 384 (7.7%) had atrial fibrillation.
Participant flow Between January 2010 and December 2016, 5007 patients who underwent FFR evaluation were screened, 2 did not meet the inclusion criteria, and 1 met the exclusion criteria. In the end, 50004 patients were enrolled and were followed until March 2020.
Adverse events No adverse event related to this study was observed due to the nature of the retrospective study.
Outcome measures During the follow up, 87 patients suffered from cardiac death and 59 patients suffered non-fatal myocardial infarction. The cumulative incidence of cardiac death was 0.44% at 1 year, 1.27% at 3 year, and 2.3% at 5 year. With regard to non-fatal myocardial infarction, the cumulative incidence was 0.27% at 1 year, 0.8% at 3 year, and 1.54% at 5 year.
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 01 Month 20 Day
Date of IRB
2018 Year 03 Month 13 Day
Anticipated trial start date
2019 Year 03 Month 01 Day
Last follow-up date
2020 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Retrospective cohort study

Management information
Registered date
2019 Year 02 Month 19 Day
Last modified on
2022 Year 08 Month 04 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040929